Endometriosis has many hypothesized etiologies. Known risk factors include genetic predisposition, uterine outflow abnormalities, and iatrogenic causes. Of increasing concern is prenatal environmental exposures. However, the findings of studies investigating the relationships between prenatal environmental exposures and the development of endometriosis have not always been conclusive, and therefore, the relationships are debatable.
Methods:
This review presents a summary and analysis of the current studies that investigated the effects of prenatal environmental exposures on the development of endometriosis in female offspring.
Results:
Prenatal exposure to estrogenic substances (such as ethinyl estradiol and diethylstilbestrol) and environmental toxins (such as 2,3,7,8-tetrachlorodibenzo-p-dioxin, polychlorinated biphenyls, and bisphenol A) may increase the incidence of endometriosis in female offspring. However, exposure to cigarette smoke may protect against the development of endometriosis in female offspring mainly because of its antiestrogenic effects.
Conclusion:
Certain prenatal environmental exposures might result in the development of endometriosis in female offspring. In addition to known environmental exposures that predispose the development of endometriosis in adulthood, such as dioxin and radiation exposure (animal models), prenatal exposures are of increasing concern.
KnappVJ. How old is endometriosis? Late 17th- and 18th-century European descriptions of the disease. Fertil Steril. 1999;72(1):10–14.
2.
BenagianoGBrosensI. History of adenomyosis. Best Pract Res Clin Obstet Gynaecol. 2006;20(4):449–463.
3.
SignorilePGBaldiFBussaniRD’ArmientoMDe FalcoMBaldiA. Ectopic endometrium in human foetuses is a common event and sustains the theory of mullerianosis in the pathogenesis of endometriosis, a disease that predisposes to cancer. J Exp Clin Cancer Res. 2009;28:49.
MehedintuCPlotogeaMNIonescuSAntonoviciM. Endometriosis still a challenge. J Med Life. 2014;7(3):349–357.
6.
AbbasSIhlePKösterISchubertI. Prevalence and incidence of diagnosed endometriosis and risk of endometriosis in patients with endometriosis-related symptoms: findings from a statutory health insurance-based cohort in Germany. Eur J Obstet Gynecol Reprod Biol. 2012;160(1):79–83.
7.
HudelistGKecksteinJWrightJT. The migrating adenomyoma: past views on the etiology of adenomyosis and endometriosis. Fertil Steril. 2009;92(5):1536–1543.
8.
KlattigJEnglertC. The Mullerian duct: recent insights into its development and regression. Sex Dev. 2007;1(5):271–278.
9.
Bouquet de JolinièreJAyoubiJMLesecG. Identification of displaced endometrial glands and embryonic duct remnants in female fetal reproductive tract: possible pathogenetic role in endometriotic and pelvic neoplastic processes. Front Physiol. 2012;3:444.
10.
HufnagelDLiFCosarEKrikunGTaylorHS. The role of stem cells in the etiology and pathophysiology of endometriosis. Semin Reprod Med. 2015;33(5):333–340.
11.
CramerDWMissmerSA. The epidemiology of endometriosis. Ann N Y Acad Sci. 2002;955:11–22; discussion 34-36, 396-406.
12.
Buck LouisGMHedigerMLPeñaJB. Intrauterine exposures and risk of endometriosis. Hum Reprod. 2007;22(12):3232–3236.
13.
CummingsAMHedgeJMBirnbaumLS. Effect of prenatal exposure to TCDD on the promotion of endometriotic lesion growth by TCDD in adult female rats and mice. Toxicol Sci. 1999;52(1):45–49.
14.
PorporaMGMeddaEAbballeA. Endometriosis and organochlorinated environmental pollutants: a case-control study on Italian women of reproductive age. Environ Health Perspect. 2009;117(7):1070–1075.
15.
CalafatAMYeXWongLYReidyJANeedhamLL. Exposure of the U.S. population to bisphenol A and 4-tertiary-octylphenol: 2003-2004. Environ Health Perspect. 2008;116(1):39–44.
16.
AldadTSRahmaniNLeranthCTaylorHS. Bisphenol-A exposure alters endometrial progesterone receptor expression in the nonhuman primate. Fertil Steril. 2011;96(1):175–179.
17.
BarkerDJ. The fetal and infant origins of adult disease. BMJ. 1990;301(6761):1111.
18.
SignorilePGBaldiFBussaniR. Embryologic origin of endometriosis: analysis of 101 human female fetuses. J Cell Physiol. 2012;227(4):1653–1656.
19.
HalesCN. Fetal and infant origins of adult disease. J Clin Pathol. 1997;50(5):359.
20.
MoenMH. Why do women develop endometriosis and why is it diagnosed?Hum Reprod. 1995;10(1):8–11.
21.
SignorilePGSpugniniEPMitaL. Pre-natal exposure of mice to bisphenol A elicits an endometriosis-like phenotype in female offspring. Gen Comp Endocrinol. 2010;168(3):318–325.
22.
FraunhofferNAMeilerman AbuelafiaAStellaIGallianoSBarriosMVitulloAD. Identification of germ cell-specific VASA and IFITM3 proteins in human ovarian endometriosis. J Ovarian Res. 2015;8:66.
23.
FettbackPBPereiraRMRochaAM. Expression of stem cell-related genes in the endometrium and endometriotic lesions: a pilot study. Gynecol Endocrinol. 2015:1–5.
24.
KhanKNFujishitaAKitajimaMHirakiKNakashimaMMasuzakiH. Occult microscopic endometriosis: undetectable by laparoscopy in normal peritoneum. Hum Reprod. 2014;29(3):462–472.
25.
HuhtinenKSaloniemi-HeinonenTKeski-RahkonenP. Intra-tissue steroid profiling indicates differential progesterone and testosterone metabolism in the endometrium and endometriosis lesions. J Clin Endocrinol Metab. 2014;99(11):e2188–e2197.
26.
HatchEEHerbstALHooverRN. Incidence of squamous neoplasia of the cervix and vagina in women exposed prenatally to diethylstilbestrol (United States). Cancer Causes Control. 2001;12(9):837–845.
27.
KirigayaAHayashiSIguchiTSatoT. Developmental effects of ethinylestradiol on reproductive organs of female mice. In Vivo. 2006;20(6b):867–873.
28.
NewboldR. Cellular and molecular effects of developmental exposure to diethylstilbestrol: implications for other environmental estrogens. Environ Health Perspect. 1995;103(suppl 7):83–87.
29.
KoikeEYasudaYShiotaM. Exposure to ethinyl estradiol prenatally and/or after sexual maturity induces endometriotic and precancerous lesions in uteri and ovaries of mice. Congenit Anom (Kyoto). 2013;53(1):9–17.
30.
GoldenRJNollerKLTitus-ErnstoffL. Environmental endocrine modulators and human health: an assessment of the biological evidence. Crit Rev Toxicol. 1998;28(2):109–227.
31.
FergusonJH. Effect of stilbestrol on pregnancy compared to the effect of a placebo. Am J Obstet Gynecol. 1953;65(3):592–601.
32.
DieckmannWJDavisMERynkiewiczLMPottingerRE. Does the administration of diethylstilbestrol during pregnancy have therapeutic value?Am J Obstet Gynecol. 1953;66(5):1062–1081.
33.
The use of hormones in the management of pregnancy in diabetics. Lancet. 1955;269(6895):833–836.
34.
HooverRNHyerMPfeifferRM. Adverse health outcomes in women exposed in utero to diethylstilbestrol. N Engl J Med. 2011;365(14):1304–1314.
35.
HerbstALUlfelderHPoskanzerDCLongoLD. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. 1971. Am J Obstet Gynecol. 1999;181(6):1574–1575.
36.
Hilakivi-ClarkeL. Maternal exposure to diethylstilbestrol during pregnancy and increased breast cancer risk in daughters. Breast Cancer Res. 2014;16(2):208.
37.
HaneyAFHammondMG. Hammond, Infertility in women exposed to diethylstilbestrol in utero. J Reprod Med. 1983;28(12):851–856.
38.
MissmerSAHankinsonSESpiegelmanDBarbieriRLMichelsKBHunterDJ. In utero exposures and the incidence of endometriosis. Fertil Steril. 2004;82(6):1501–1508.
39.
BenagianoGBrosensI. In utero exposure and endometriosis. J Matern Fetal Neonatal Med. 2014;27(3):303–308.
40.
WolffEFSunLHedigerML. In utero exposures and endometriosis: the Endometriosis, Natural History, Disease, Outcome (ENDO) Study. Fertil Steril. 2013;99(3):790–795.
41.
RenXWuXHillierSG. Local estrogen metabolism in epithelial ovarian cancer suggests novel targets for therapy. J Steroid Biochem Mol Biol. 2015;150:54–63.
DeMayoFJZhaoBTakamotoNTsaiSY. Mechanisms of action of estrogen and progesterone. Ann N Y Acad Sci. 2002;955:48–59; discussion 86-88, 396-406.
44.
SumitaniHShozuMSegawaT. In situ estrogen synthesized by aromatase P450 in uterine leiomyoma cells promotes cell growth probably via an autocrine/intracrine mechanism. Endocrinology. 2000;141(10):3852–3861.
45.
BulunSEYangSFangZ. Role of aromatase in endometrial disease. J Steroid Biochem Mol Biol. 2001;79(1-5):19–25.
46.
BruneRMBardJBDubreuilC. A three-dimensional model of the mouse at embryonic day 9. Dev Biol. 1999;216(2):457–468.
47.
ShaoRCaoSWangXFengYBilligH. The elusive and controversial roles of estrogen and progesterone receptors in human endometriosis. Am J Transl Res. 2014;6(2):104–113.
48.
BurnsKAKorachKS. Estrogen receptors and human disease: an update. Arch Toxicol. 2012;86(10):1491–1504.
49.
HapangamaDKKamalAMBulmerJN. Estrogen receptor beta: the guardian of the endometrium. Hum Reprod Update. 2015;21(2):174–193.
50.
RileyCFMoenMHVidemV. Inflammatory markers in endometriosis: reduced peritoneal neutrophil response in minimal endometriosis. Acta Obstet Gynecol Scand. 2007;86(7):877–881.
51.
WangYQYinLRGuoRMShengW. Role of epidermal growth factor signaling system in the pathogenesis of endometriosis under estrogen deprivation conditions. Zhonghua Fu Chan Ke Za Zhi. 2013;48(6):447–452.
52.
SchoetersGDen HondEDhoogeWvan LarebekeNLeijsM. Endocrine disruptors and abnormalities of pubertal development. Basic Clin Pharmacol Toxicol. 2008;102(2):168–175.
53.
HotchkissAKRiderCVBlystoneCR. Fifteen years after “Wingspread”—environmental endocrine disrupters and human and wildlife health: where we are today and where we need to go. Toxicol Sci. 2008;105(2):235–259.
54.
Jacobson-DickmanELeeMM. The influence of endocrine disruptors on pubertal timing. Curr Opin Endocrinol Diabetes Obes. 2009;16(1):25–30.
55.
GrayLEJrOstbyJS. In utero 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) alters reproductive morphology and function in female rat offspring. Toxicol Appl Pharmacol. 1995;133(2):285–294.
56.
CoutureLAHarrisMWBirnbaumLS. Characterization of the peak period of sensitivity for the induction of hydronephrosis in C57BL/6N mice following exposure to 2,3,7, 8-tetrachlorodibenzo-p-dioxin. Fundam Appl Toxicol. 1990;15(1):142–150.
57.
Bruner-TranKLDingTOsteenKG. Dioxin and endometrial progesterone resistance. Semin Reprod Med. 2010;28(1):59–68.
58.
GuoSW. The link between exposure to dioxin and endometriosis: a critical reappraisal of primate data. Gynecol Obstet Invest. 2004;57(3):157–173.
59.
GuoSWSimsaPKyamaCM. Reassessing the evidence for the link between dioxin and endometriosis: from molecular biology to clinical epidemiology. Mol Hum Reprod. 2009;15(10):609–624.
60.
OkinoSTWhitlockJPJr. The aromatic hydrocarbon receptor, transcription, and endocrine aspects of dioxin action. Vitam Horm. 2000;59:241–264.
61.
SherrDH. Another important biological function for the aryl hydrocarbon receptor. Arterioscler Thromb Vasc Biol. 2011;31(6):1247–1248.
62.
SherrDHMontiS. The role of the aryl hydrocarbon receptor in normal and malignant B cell development. Semin Immunopathol. 2013;35(6):705–716.
63.
MimuraJFujii-KuriyamaY. Functional role of AhR in the expression of toxic effects by TCDD. Biochim Biophys Acta. 2003;1619(3):263–268.
64.
OsteenKGBruner-TranKLEisenbergE. Reduced progesterone action during endometrial maturation: a potential risk factor for the development of endometriosis. Fertil Steril. 2005;83(3):529–537.
65.
NayyarTBruner-TranKLPiestrzeniewicz-UlanskaDOsteenKG. Developmental exposure of mice to TCDD elicits a similar uterine phenotype in adult animals as observed in women with endometriosis. Reprod Toxicol. 2007;23(3):326–336.
66.
Bruner-TranKLOsteenKG. Dioxin-like PCBs and endometriosis. Syst Biol Reprod Med. 2010;56(2):132–146.
67.
QuarantaMGPorporaMGMattioliB. Impaired NK-cell-mediated cytotoxic activity and cytokine production in patients with endometriosis: a possible role for PCBs and DDE. Life Sci. 2006;79(5):491–498.
68.
MaffiniMVRubinBSSonnenscheinCSotoAM. Endocrine disruptors and reproductive health: the case of bisphenol-A. Mol Cell Endocrinol. 2006;254-255:179–186.
69.
UpsonKSathyanarayanaSDe RoosAJKochHMScholesDHoltVL. A population-based case-control study of urinary bisphenol A concentrations and risk of endometriosis. Hum Reprod. 2014;29(11):2457–2464.
70.
AgarwalDKEustisSLambJCIVReelJRKluweWM. Effects of di(2-ethylhexyl) phthalate on the gonadal pathophysiology, sperm morphology, and reproductive performance of male rats. Environ Health Perspect. 1986;65:343–350.
71.
HonmaSSuzukiABuchananDLKatsuYWatanabeHIguchiT. Low dose effect of in utero exposure to bisphenol A and diethylstilbestrol on female mouse reproduction. Reprod Toxicol. 2002;16(2):117–122.
72.
Diamanti-KandarakisEBourguignonJPGiudiceLC. Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr Rev. 2009;30(4):293–342.
73.
BosquiazzoVLVigezziLMuñoz-de-ToroMLuqueEH. Perinatal exposure to diethylstilbestrol alters the functional differentiation of the adult rat uterus. J Steroid Biochem Mol Biol. 2013;138:1–9.
74.
QuignotNArnaudMRobidelF. Characterization of endocrine-disrupting chemicals based on hormonal balance disruption in male and female adult rats. Reprod Toxicol. 2012;33(3):339–352.
75.
PrinsGS. Estrogen imprinting: when your epigenetic memories come back to haunt you. Endocrinology. 2008;149(12):5919–5921.
76.
ZanattaAPereiraRMRochaAM. The relationship among HOXA10, estrogen receptor alpha, progesterone receptor, and progesterone receptor B proteins in rectosigmoid endometriosis: a tissue microarray study. Reprod Sci. 2015;22(1):31–37.
77.
McGinnisWKrumlaufR. Homeobox genes and axial patterning. Cell. 1992;68(2):283–302.
78.
ZanattaARochaAMCarvalhoFM. The role of the Hoxa10/HOXA10 gene in the etiology of endometriosis and its related infertility: a review. J Assist Reprod Genet. 2010;27(12):701–710.
79.
HammoudAOBujoldESorokinYSchildCKrappMBaumannP. Smoking in pregnancy revisited: findings from a large population-based study. Am J Obstet Gynecol. 2005;192(6):1856–1862; discussion 1862-1863.
80.
HarrodCSReynoldsRMChasan-TaberL. Quantity and timing of maternal prenatal smoking on neonatal body composition: the Healthy Start study. J Pediatr. 2014;165(4):707–712.
81.
KalePLFonsecaSCda SilvaKS. Smoking prevalence, reduction, and cessation during pregnancy and associated factors: a cross-sectional study in public maternities, Rio de Janeiro, Brazil. BMC Public Health. 2015;15:406.
82.
EnglandLJLevineRJQianC. Smoking before pregnancy and risk of gestational hypertension and preeclampsia. Am J Obstet Gynecol. 2002;186(5):1035–1040.
83.
SomiglianaEViganoPAbbiatiA. Perinatal environment and endometriosis. Gynecol Obstet Invest. 2011;72(2):135–140.
84.
NicklasBJTomoyasuNMuirJGoldbergAP. Effects of cigarette smoking and its cessation on body weight and plasma leptin levels. Metabolism. 1999;48(6):804–808.
85.
LiPBeckWDCallahanPMTerryAVJrBartlettMG. Pharmacokinetics of cotinine in rats: a potential therapeutic agent for disorders of cognitive function. Pharmacol Rep. 2015;67(3):494–500.
86.
IveyRDesaiMGreenKSinha-HikimIFriedmanTCSinha-HikimAP. Additive effects of nicotine and high-fat diet on hepatocellular apoptosis in mice: involvement of caspase 2 and inducible nitric oxide synthase-mediated intrinsic pathway signaling. Horm Metab Res. 2014;46(8):568–573.
87.
RochaALReisFMTaylorRN. Angiogenesis and endometriosis. Obstet Gynecol Int. 2013;2013:859619.
88.
GrizzellJAMullinsMIarkovARohaniACharryLCEcheverriaV. Cotinine reduces depressive-like behavior and hippocampal vascular endothelial growth factor downregulation after forced swim stress in mice. Behav Neurosci. 2014;128(6):713–721.
89.
CookeJPBittermanH. Nicotine and angiogenesis: a new paradigm for tobacco-related diseases. Ann Med. 2004;36(1):33–40.
90.
XanthouleaSDeliaertARomanoARensenSSBuurmanWAvan der HulstRR. Nicotine effect on inflammatory and growth factor responses in murine cutaneous wound healing. Int Immunopharmacol. 2013;17(4):1155–1164.
91.
WuYWangLPPanJQ. Nicotinic acetylcholine receptor agonists may be a novel therapy for endometriosis. Med Hypotheses. 2011;77(5):745–747.
92.
de JongeWJvan der ZandenEPTheFO. Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat Immunol. 2005;6(8):844–851.
93.
TraceyKJ. The inflammatory reflex. Nature. 2002;420(6917):853–859.
94.
KobayashiHImanakaSNakamuraHTsujiA. Understanding the role of epigenomic, genomic and genetic alterations in the development of endometriosis (review). Mol Med Rep. 2014;9(5):1483–1505.
